ID   LPL1_YEAST              Reviewed;         450 AA.
AC   Q08448; D6W2C2; O00022;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-JUN-2025, entry version 171.
DE   RecName: Full=Lipid droplet phospholipase 1 {ECO:0000303|PubMed:25014274};
DE            EC=3.1.-.- {ECO:0000269|PubMed:25014274};
DE            EC=3.1.1.4 {ECO:0000269|PubMed:25014274};
GN   Name=LPL1 {ECO:0000303|PubMed:25014274}; OrderedLocusNames=YOR059C;
GN   ORFNames=YOR29-10;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 96604 / S288c / FY1679;
RX   PubMed=9133743;
RX   DOI=10.1002/(sici)1097-0061(19970330)13:4<379::aid-yea85>3.0.co;2-g;
RA   Valens M., Bohn C., Daignan-Fornier B., Dang V.-D., Bolotin-Fukuhara M.;
RT   "The sequence of a 54.7 kb fragment of yeast chromosome XV reveals the
RT   presence of two tRNAs and 24 new open reading frames.";
RL   Yeast 13:379-390(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169874; DOI=10.1038/387s098;
RA   Dujon B., Albermann K., Aldea M., Alexandraki D., Ansorge W., Arino J.,
RA   Benes V., Bohn C., Bolotin-Fukuhara M., Bordonne R., Boyer J., Camasses A.,
RA   Casamayor A., Casas C., Cheret G., Cziepluch C., Daignan-Fornier B.,
RA   Dang V.-D., de Haan M., Delius H., Durand P., Fairhead C., Feldmann H.,
RA   Gaillon L., Galisson F., Gamo F.-J., Gancedo C., Goffeau A., Goulding S.E.,
RA   Grivell L.A., Habbig B., Hand N.J., Hani J., Hattenhorst U., Hebling U.,
RA   Hernando Y., Herrero E., Heumann K., Hiesel R., Hilger F., Hofmann B.,
RA   Hollenberg C.P., Hughes B., Jauniaux J.-C., Kalogeropoulos A.,
RA   Katsoulou C., Kordes E., Lafuente M.J., Landt O., Louis E.J., Maarse A.C.,
RA   Madania A., Mannhaupt G., Marck C., Martin R.P., Mewes H.-W., Michaux G.,
RA   Paces V., Parle-McDermott A.G., Pearson B.M., Perrin A., Pettersson B.,
RA   Poch O., Pohl T.M., Poirey R., Portetelle D., Pujol A., Purnelle B.,
RA   Ramezani Rad M., Rechmann S., Schwager C., Schweizer M., Sor F., Sterky F.,
RA   Tarassov I.A., Teodoru C., Tettelin H., Thierry A., Tobiasch E.,
RA   Tzermia M., Uhlen M., Unseld M., Valens M., Vandenbol M., Vetter I.,
RA   Vlcek C., Voet M., Volckaert G., Voss H., Wambutt R., Wedler H.,
RA   Wiemann S., Winsor B., Wolfe K.H., Zollner A., Zumstein E., Kleine K.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XV.";
RL   Nature 387:98-102(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10515935; DOI=10.1128/jb.181.20.6441-6448.1999;
RA   Athenstaedt K., Zweytick D., Jandrositz A., Kohlwein S.D., Daum G.;
RT   "Identification and characterization of major lipid particle proteins of
RT   the yeast Saccharomyces cerevisiae.";
RL   J. Bacteriol. 181:6441-6448(1999).
RN   [5]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [6]
RP   INDUCTION.
RX   PubMed=19073890; DOI=10.1091/mbc.e08-02-0140;
RA   Metzger M.B., Michaelis S.;
RT   "Analysis of quality control substrates in distinct cellular compartments
RT   reveals a unique role for Rpn4p in tolerating misfolded membrane
RT   proteins.";
RL   Mol. Biol. Cell 20:1006-1019(2009).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, DOMAIN, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF GLY-88; SER-90
RP   AND GLY-92.
RX   PubMed=25014274; DOI=10.1016/j.bbalip.2014.06.013;
RA   Selvaraju K., Rajakumar S., Nachiappan V.;
RT   "Identification of a phospholipase B encoded by the LPL1 gene in
RT   Saccharomyces cerevisiae.";
RL   Biochim. Biophys. Acta 1842:1383-1392(2014).
CC   -!- FUNCTION: Phospholipase involved in maintaining the lipid droplet
CC       morphology (PubMed:25014274). Has phospholipase activity with broad
CC       substrate specificity, acting on glycerophospholipids
CC       phosphatidylethanolamine (PE), phosphatidic acid (PA),
CC       phosphatidycholine (PC) and phosphatidylserine (PS), primarily at sn-2
CC       position (PubMed:25014274). It can later remove fatty acids from the
CC       sn-1 position of the produced lysophospholipids such as
CC       lysophosphatidylethanolamine (LPE) (PubMed:25014274). Also shows
CC       activity toward phosphatidylglycerol, but, in contrast to what was
CC       observed with the other phospholipids tested, prefers the sn-1 position
CC       (PubMed:25014274). {ECO:0000269|PubMed:25014274}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + H2O = a 1-
CC         acyl-sn-glycero-3-phosphoethanolamine + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:44604, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:64381, ChEBI:CHEBI:64612;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44605;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphoethanolamine + H2O = sn-glycero-
CC         3-phosphoethanolamine + a fatty acid + H(+); Xref=Rhea:RHEA:32967,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:64381, ChEBI:CHEBI:143890;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32968;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphate + H2O = a 1-acyl-sn-
CC         glycero-3-phosphate + a fatty acid + H(+); Xref=Rhea:RHEA:44420,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57970, ChEBI:CHEBI:58608;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44421;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15802;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-L-serine + H2O = a 1-acyl-
CC         sn-glycero-3-phospho-L-serine + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:44672, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:57262, ChEBI:CHEBI:64379;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44673;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphoglycerol + H2O = a 2-acyl-sn-
CC         glycero-3-phosphoglycerol + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:62032, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:145393, ChEBI:CHEBI:145394;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62033;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-(9Z-octadecenoyl)-2-acyl-sn-glycero-3-phosphocholine + H2O
CC         = 1-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:62036, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28610, ChEBI:CHEBI:28868, ChEBI:CHEBI:78421;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62037;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-(9Z-octadecenoyl)-2-acyl-sn-glycero-3-phosphoglycerol +
CC         H2O = a 2-acyl-sn-glycero-3-phosphoglycerol + (9Z)-octadecenoate +
CC         H(+); Xref=Rhea:RHEA:62044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:145392, ChEBI:CHEBI:145393;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62045;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-aryl-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine
CC         + H2O = an N-aryl-1-hexadecanoyl-sn-glycero-3-phosphoethanolamine +
CC         hexadecanoate + H(+); Xref=Rhea:RHEA:62048, ChEBI:CHEBI:7896,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:145395,
CC         ChEBI:CHEBI:145396; Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62049;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-(9Z-octadecenoyl)-2-acyl-sn-glycero-3-phosphate + H2O = 1-
CC         (9Z-octadecenoyl)-sn-glycero-3-phosphate + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:62052, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:74544, ChEBI:CHEBI:145397;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62053;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine + H2O = 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + hexadecanoate + H(+);
CC         Xref=Rhea:RHEA:62100, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:73004, ChEBI:CHEBI:73005;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62101;
CC         Evidence={ECO:0000269|PubMed:25014274};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.86 mM for phosphatidylethanolamine (PE)
CC         {ECO:0000269|PubMed:25014274};
CC         KM=0.97 mM for phosphatidic acid (PA) {ECO:0000269|PubMed:25014274};
CC         KM=1.12 mM for phosphatidylglycerol (PG)
CC         {ECO:0000269|PubMed:25014274};
CC         KM=0.83 mM for phosphatidycholine (PC) {ECO:0000269|PubMed:25014274};
CC         KM=0.92 mM for phosphatidylserine (PS) {ECO:0000269|PubMed:25014274};
CC         Vmax=4.55 umol/min/mg enzyme toward phosphatidylethanolamine (PE)
CC         {ECO:0000269|PubMed:25014274};
CC         Vmax=4.05 umol/min/mg enzyme toward phosphatidic acid (PA)
CC         {ECO:0000269|PubMed:25014274};
CC         Vmax=3.25 umol/min/mg enzyme toward phosphatidylglycerol (PG)
CC         {ECO:0000269|PubMed:25014274};
CC         Vmax=1.65 umol/min/mg enzyme toward phosphatidycholine (PC)
CC         {ECO:0000269|PubMed:25014274};
CC         Vmax=1.05 umol/min/mg enzyme toward phosphatidylserine (PS)
CC         {ECO:0000269|PubMed:25014274};
CC   -!- SUBCELLULAR LOCATION: Lipid droplet {ECO:0000269|PubMed:10515935,
CC       ECO:0000269|PubMed:25014274}. Membrane {ECO:0000255}; Single-pass
CC       membrane protein {ECO:0000255}.
CC   -!- INDUCTION: Expression is up-regulated by the transcription factor RPN4.
CC       {ECO:0000269|PubMed:19073890}.
CC   -!- DISRUPTION PHENOTYPE: Leads to an altered morphology of lipid droplets
CC       with a smaller size. {ECO:0000269|PubMed:25014274}.
CC   -!- MISCELLANEOUS: Present with 1210 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the putative lipase ROG1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z70678; CAA94544.1; -; Genomic_DNA.
DR   EMBL; Z74967; CAA99252.1; -; Genomic_DNA.
DR   EMBL; BK006948; DAA10838.1; -; Genomic_DNA.
DR   PIR; S66942; S66942.
DR   RefSeq; NP_014702.1; NM_001183478.1.
DR   AlphaFoldDB; Q08448; -.
DR   BioGRID; 34458; 76.
DR   DIP; DIP-4169N; -.
DR   FunCoup; Q08448; 168.
DR   IntAct; Q08448; 6.
DR   STRING; 4932.YOR059C; -.
DR   SwissLipids; SLP:000001976; -.
DR   ESTHER; yeast-yo059; Duf_676.
DR   PaxDb; 4932-YOR059C; -.
DR   PeptideAtlas; Q08448; -.
DR   EnsemblFungi; YOR059C_mRNA; YOR059C; YOR059C.
DR   GeneID; 854225; -.
DR   KEGG; sce:YOR059C; -.
DR   AGR; SGD:S000005585; -.
DR   SGD; S000005585; LPL1.
DR   VEuPathDB; FungiDB:YOR059C; -.
DR   eggNOG; KOG4372; Eukaryota.
DR   HOGENOM; CLU_027968_2_0_1; -.
DR   InParanoid; Q08448; -.
DR   OMA; DWIKIPV; -.
DR   OrthoDB; 273452at2759; -.
DR   BioCyc; YEAST:G3O-33599-MONOMER; -.
DR   BioGRID-ORCS; 854225; 0 hits in 10 CRISPR screens.
DR   PRO; PR:Q08448; -.
DR   Proteomes; UP000002311; Chromosome XV.
DR   RNAct; Q08448; protein.
DR   GO; GO:0005783; C:endoplasmic reticulum; HDA:SGD.
DR   GO; GO:0005811; C:lipid droplet; IDA:SGD.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004622; F:lysophospholipase activity; IDA:SGD.
DR   GO; GO:0047372; F:monoacylglycerol lipase activity; IBA:GO_Central.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0055088; P:lipid homeostasis; IMP:SGD.
DR   GO; GO:0006629; P:lipid metabolic process; IBA:GO_Central.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase_fold.
DR   InterPro; IPR007751; DUF676_lipase-like.
DR   InterPro; IPR044294; Lipase-like.
DR   PANTHER; PTHR12482; LIPASE ROG1-RELATED-RELATED; 1.
DR   PANTHER; PTHR12482:SF24; LIPID DROPLET PHOSPHOLIPASE 1; 1.
DR   Pfam; PF05057; DUF676; 1.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS00120; LIPASE_SER; 1.
PE   1: Evidence at protein level;
KW   Hydrolase; Lipid degradation; Lipid droplet; Lipid metabolism; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..450
FT                   /note="Lipid droplet phospholipase 1"
FT                   /id="PRO_0000237649"
FT   TRANSMEM        269..289
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOTIF           88..92
FT                   /note="Lipase-specific GXSXG motif"
FT                   /evidence="ECO:0000269|PubMed:25014274"
FT   ACT_SITE        90
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10037"
FT   MUTAGEN         88
FT                   /note="G->A: Completely abolishes the phospholipase
FT                   activity; when associated with A-90 and A-92."
FT                   /evidence="ECO:0000269|PubMed:25014274"
FT   MUTAGEN         90
FT                   /note="S->A: Partially abolishes the phospholipase activity
FT                   towards PS and PA. Completely abolishes the phospholipase
FT                   activity; when associated with A-88 and A-92."
FT                   /evidence="ECO:0000269|PubMed:25014274"
FT   MUTAGEN         92
FT                   /note="G->A: Completely abolishes the phospholipase
FT                   activity; when associated with A-88 and A-90."
FT                   /evidence="ECO:0000269|PubMed:25014274"
SQ   SEQUENCE   450 AA;  51106 MW;  E04CCDA6FCE96AAD CRC64;
     MTSDKHLFVL IHGLWGNYTH MESMRTILST TLKKEDVNDD MIYFLPKQNA MFKTFDGIEI
     IGYRTLIEVC EFIRDYKDGK ITKLSVMGYS QGGLVARFMI GKMLTEFKEL FEDIEPQLFI
     TMATPHLGVE FYNPTGIAYK SALYSALRTL GSTILGKSGR EMFIANSSNN ILVKLSQGEY
     LEALSLFKWR IAFANVKNDR TVAFYTAFIT DCDPFIDFDN KLKYTFEEKI PGSGYKGILP
     KIVDLNALNV NSHAPTKPTK TYKKWGRTIL IILVATFLIL PIALVMNGLG TAYSYIVTCK
     YRKMLSNGIL HNEVRGKLGL TEQLKGYVTD AYGSIINSAL DMDANYEASN SNLVNEEELP
     WKEFIQKYTT INDGVWKSKF KKLPFDENRK VILRNLNKLK WIRVPIYIKA VNAHGVIVAR
     RGMDENTAAT GIACIEFTAQ LLAYLMHKSN
//
